Innovative immunotherapies for cancer are a step closer to reality thanks to a commercial licence agreement between Australia’s Cartherics Pty. Ltd. and South Korea-based ToolGen, Inc.
Melbourne, Australia and Seoul, South Korea
28 June 2021
Cartherics Pty Ltd (“Cartherics”) and ToolGen, Inc. (“ToolGen”) announced today that they have entered into a commercial licence agreement.
Under the agreement, Cartherics obtains […]